Medifast Inc. (NYSE: MED) stock suffered a major decline of -11.4% on 2/19/25. The shares closed at $14.29. Moreover, this decline was accompanied by exceptionally high trading volume at 293% of normal. The stock has been weak relative to the market over the last nine months and has declined -5.9% during the last week.
Current PriceTarget Research Rating
Medifast has a current Value Trend Rating of D (Negative). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. Medifast has a neutral Appreciation Score of 45 but a poor Power Rating of 21, producing the Negative Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment